Hostname: page-component-76fb5796d-9pm4c Total loading time: 0 Render date: 2024-04-25T17:09:29.261Z Has data issue: false hasContentIssue false
  • English
  • Français

Serotonergic Dysfunction in Depression

Published online by Cambridge University Press:  06 August 2018

Herbert Meltzer
Herbert Meltzer*
Affiliation:
Department of Psychiatry, Case Western Reserve University School of Medicine, Cleveland, Ohio
Get access Rights & Permissions [Opens in a new window]

Extract

Various irregularities in serotonin (5-HT) function have been postulated as causes of affective disorders. Serotonin has been related to many of the major symptoms of depression, e.g. mood, appetite, sleep, activity, and cognitive dysfunction. Interference with 5-HT synthesis or storage has been shown to induce depression in vulnerable individuals. Decreased levels of 5-hydroxyindoleacetic acid (5-HIAA) in cerebrospinal fluid, decreased plasma tryptophan, low tryptophan neutral amino acid ratio, abnormalities in serotonergic function indicated by neuroendocrine challenge tests and various platelet measures, have been reported in depressed patients. Concentrations of 5-HIAA, the major metabolite of 5-HT in plasma, were found to be significantly negatively correlated with severity of depression as measured by the Hamilton Rating Scale for Depression score and specific depressive symptoms, despite the fact that plasma 5-HIAA is largely peripheral in origin. Blood platelets, which have been suggested as models for serotonergic nerve terminals, have a significantly decreased number of 5-HT uptake sites and 3H-imipramine binding sites in depressed patients. Antidepressant drugs may act, in part, by enhancing serotonergic activity. The serotonergic deficit may occur at any of several levels: diminished availability of precursor, impaired activity of tryptophan hydroxylase, abnormalities in 5-HT release or uptake, 5-HT receptor abnormalities or interactions with other neurotransmitters.

Type
Research Article
Information
The British Journal of Psychiatry , Volume 155 , Issue S8: SEROTONIN IN BEHAVIOURAL DISORDERS , December 1989 , pp. 25 - 31
Copyright
Copyright © Royal College of Psychiatrists, 1989 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Aprison, M. H., Takahashi, R. & Tachiki, K. (1977) Hypersensitive serotonergic receptors involved in clinical depression — a theory. In Neuropharmacology and Behavior (eds Haber, B. & Aprison, M.), pp. 23–53. New York: Pergamon Press.Google Scholar
Arora, R. C. & Meltzer, H. Y. (1989a) Serotonergic measures in the brains of suicide victims: 5-HT2 binding sites in the frontal cortex of suicide victims and normal control subjects. American Journal of Psychiatry, 146 730–736.Google Scholar
Arora, R. C. & Meltzer, H. Y. (1989b) Increased serotonin2 (5-HT2) receptor binding as measured by 3H-lysergic acid diethylamide (3H-LSD) in the blood platelets of depressed patients. Life Sciences, 44, 725–734.Google Scholar
Arora, R. C. & Meltzer, H. Y. (in press) 3H-imipramine binding in the frontal cortex of suicides. Psychiatry Research.Google Scholar
Åsberg, M., Bertilsson, L., Martensson, B., et al (1984) CSF monoamine metabolits in melancholia. Acta Psychiatrica Scandinavica, 69, 201–219.CrossRefGoogle Scholar
Barraclough, B., Bunch, J., Nelson, B., et al (1974) British Journal of Psychiatry, 125, 355–373.Google Scholar
Biegon, A., Weizman, A., Karp, L., et al (1987) Serotonin 5-HT2 receptor binding on blood platelets — a peripheral marker for depression? Life Sciences, 41, 2485–2492.CrossRefGoogle ScholarPubMed
Blundell, J. E. (1984) Serotonin and appetite. Neuropharmacology, 23 1537–1551.Google Scholar
Charney, D. S., Heninger, G. R. & Sternberg, D. E. (1984) Serotonin function and mechanism of action of antidepressant treatment: effects of amitriptyline and desipramine. Archives of General Psychiatry, 41, 359–365.Google Scholar
Coccaro, E. F., Siever, L. J., Klar, H. M., et al (1989) Serotonergic studies in patients with affective and personality disorders: correlates with suicidal and aggressive behavior. Archives of General Psychiatry, 46, 587–599.Google Scholar
Coppen, A. (1967) The biochemistry of affective disorders. British Journal of Psychiatry, 113, 1237–1264.Google Scholar
Coppen, A. & Wood, K. (1978) Tryptophan and depressive illness. Psychological Medicine, 8, 49–57.Google Scholar
Coppen, A., Prange, A. J. Jr., Whybrow, P. C., et al (1972) Abnormalities of indoleamines in affective disorders. Archives of General Psychiatry, 26, 474–478.Google Scholar
Coppen, A., Swade, C. & Wood, K. (1978) Platelet 5-hydroxytryptamine accumulation in depressive illness. Clinica Chimica Acta, 87, 165–168.Google Scholar
Cowen, P. J., Parry-Billings, M. & Newsholme, E. A. (1989) Decreased plasma tryptophan levels in major depression. Journal of Affective Disorders, 16, 27–31.Google Scholar
Cunningham, K. A., Callahan, P. M. & Appel, J. B. (1986) Discriminative stimulus properties of the serotonin agonist MK 212. Psychopharmacology (Berlin), 90, 193–197.Google Scholar
Demeter, E., Tekes, K., Majorossy, K., et al (1986) The asymmetry of 3H-imipramine binding may predict psychiatric illness. Life Sciences, 44, 1403–1410.CrossRefGoogle Scholar
DeMyer, M. K., Shea, P. A., Hendrie, H. C., et al (1981) Plasma tryptophan and five other amino acids in depressed and normal subjects. Archives of General Psychiatry, 38, 642–646.CrossRefGoogle ScholarPubMed
Endicott, J. & Spitzer, R. L. (1978) A diagnostic interview: the schedule for affective disorders and schizophrenia. Archives of General Psychiatry, 35, 837–844.Google Scholar
Geany, D. P., Schachter, M., Elliott, J. M., et al (1984) Characterisation of [3H] lysergic acid diethylamide binding to a 5-hydroxytryptamine receptor on platelet membranes. European Journal of Pharmacology, 97, 87–93.CrossRefGoogle Scholar
Goodwin, P. K. & Bunney, W. E. (1971) Depression following reserpine: a re-evaluation. Seminars in Psychiatry, 3, 435–448.Google Scholar
Gross-Isseroff, R., Israeli, M. & Biegon, A. (1989) Autoradiographic analysis of tritiated imipramine binding in the human brain post mortem: effects of suicide. Archives of General Psychiatry, 46, 237–241.Google Scholar
Hamilton, M. (1960) A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 56–62.CrossRefGoogle ScholarPubMed
Healy, D., O'Halloran, A., Carney, P. A., et al (1986). Platelet 5-HT uptake in delusional and nondelusional depressions. Journal of Affective Disorders, 10, 233–239.CrossRefGoogle Scholar
Heninger, G. R., Charney, D. S. & Sternberg, D. E. (1984) Serotonergic function in depression: prolactin response to intravenous tryptophan in depressed patients and healthy subjects. Archives of General Psychiatry, 41, 398–402.Google Scholar
Heninger, G. R., Delgado, P., Charney, D., et al (1989) Behavioral effects of acute tryptophan depletion in depressed patients. Biological Psychiatry, 25, 143A.CrossRefGoogle Scholar
Koyama, T. & Meltzer, H. Y. (1986) A biochemical and neuroendocrine study of the serotonergic system in depression. In New Results in Depression Research (eds Hippius, H., Klerman, G. L. & Matussek, N.), pp. 164–188. Berlin, New York: Springer-Verlag.Google Scholar
Koyama, T., Lowy, M. T. & Meltzer, H. Y. (1987) 5-Hydroxytryptophan-induced cortisol response and CSF 5-HIAA in depressed patients. American Journal of Psychiatry, 144, 334–337.Google Scholar
Lapin, I. P. & Oxenkrug, G. F. (1969) Intensification of the central serotoninergic processes as a possible determinant of the thymoleptic effect. Lancet, i, 132–136.CrossRefGoogle Scholar
Lowy, M. T. & Meltzer, H. Y. (1988) Stimulation of serum cortisol and prolactin secretion in humans by MK-212, a centrally active serotonin agonist. Biological Psychiatry, 23, 818–828.Google Scholar
Maes, M., DeRuyter, M., Claes, R., et al (1987) The cortisol response to 5-hydroxytryptophan, orally, in depressive inpatients. Journal of Affective Disorders, 13, 23–30.Google Scholar
Mann, J. J., Stanley, M., McBride, A., et al (1986) Increased serotonin2 and β-adrenergic receptor binding in the frontal cortices of suicide victims. Archives of General Psychiatry, 43, 954–959.Google Scholar
Meltzer, H. Y. & Lowy, M. T. (1987) The serotonin hypothesis of depression. In Psychopharmacology, The Third Generation of Progress. (ed. Meltzer, H. Y.), pp. 513–526. New York: Raven Press.Google Scholar
Meltzer, H. Y., Arora, R. C., Baber, R., et al (1981) Serotonin uptake in blood platelets of psychiatric patients. Archives of General Psychiatry, 38, 1322–1326.Google Scholar
Meltzer, H. Y., Lowy, M., Robertson, A., et al (1984b) Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. III Effect of antidepressants and lithium carbonate. Archives of General Psychiatry, 41, 391–402.Google Scholar
Meltzer, H. Y., Perline, R., Tricon, B. J., et al. (1984c) Effects of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. II. Relation to suicide, psychosis and depressive symptoms. Archives of General Psychiatry, 41, 391–402.Google Scholar
Meltzer, H. Y., Umberkoman-Wiita, B., Robertson, A., et al (1984d) Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders: I. Enhanced response in depression and mania. Archives of General Psychiatry, 41, 366–374.Google Scholar
M⊘ller, S. E., (1985) Tryptophan to competing amino acid ratios in depression disorder: relation to efficacy of antidepressive treatments. Acta Psychiatrica Scandinavica (Suppl. 325), 72, 1–31.Google Scholar
M⊘ller, S. E., Kirk, L. & Honoré, P. (1980) Relationship between plasma ratio of tryptophan to competing amino acids and the response to L-tryptophan treatment in endogenously depressed patients. Journal of Affective Disorders, 2, 47–59.CrossRefGoogle Scholar
Owen, F., Chambers, D. R., Cooper, S. K., et al (1986) Serotonergic mechanisms in brains of suicide victims. Brain Research, 362, 185–188.CrossRefGoogle ScholarPubMed
Pericic, D. & Manev, H. (1988) Behavioural evidence for simultaneous dual changes of 5-HT receptor subtypes: mode of antidepressent action? Life Sciences, 42, 2593–2601.Google Scholar
Potter, W. Z., Rudorfer, M. V., Pickar, D., et al (1987) Effects of psychotropic drugs on neurotransmitters in man. Life Sciences, 41, 817–820.CrossRefGoogle ScholarPubMed
Robins, E., Murphy, G. E., Wilkinson, R. H., et al (1959) Some clinical considerations in the prevention of suicide based on a study of 134 successful suicides. American Journal of Public Health, 49, 888–899.Google Scholar
Shopsin, B., Friedman, E. & Gershon, S. (1976) Parachlorphenylalanine reversal of tranylcypromine effects in depressed patients. Archives of General Psychiatry, 33, 811–819.CrossRefGoogle Scholar
Smith, S. E., Pihl, R. O., Young, S. N., et al (1987) A test of possible cognitive and environmental influences on the mood lowering effect of tryptophan depletion in normal males. Psychopharmacology, 91, 451–457.Google Scholar
Stanley, M., Virgilio, J. & Gershon, S. (1982) Tritiated imipramine binding sites are decreased in the frontal cortex of suicides. Science, 216, 1337–1339.CrossRefGoogle ScholarPubMed
Suranyi-Cadotte, B. E., Quirion, R., Nair, N. P. V., et al (1985) Imipramine treatment differentially affects platelet 3H-imipramine binding and serotonin uptake in depressed patients. Life Sciences, 36, 795–799.Google Scholar
Young, S. N., Pihl, R. O. & Ervin, F. R. (1986) The effect of altered tryptophan levels on mood and behavior in normal human males. Clinical Neuropharmacology, 9 (Suppl. 4), 516–518.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.